
Sign up to save your podcasts
Or


In episode 81 of Going anti-Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. Dr Deeks and Dr Saag discuss why a cure for HIV is needed given the effectiveness antiretroviral therapy. Dr Deeks then outlines areas of research demonstrating promise for single-shot functional cures: vector immunotherapy, the use of Chimeric Antigen Receptor (CAR) T cells, and stem cell approaches. Finally, Dr Deeks provides insights into future prospects in HIV cure research including his perspective on the funding and drug development landscape.
0:00 – Introduction
1:21 – The need for a cure beyond antiretroviral therapy
5:37 – Overview of 1-shot cure research
12:40 – The promise of vector immunotherapy
18:52 – Overview of the use of CAR-T cells
25:01 – The role of C-C chemokine receptor type 5 (CCR5) and stem cell approaches
26:36 – Prospects for the future of HIV cure research
__________________________________________________
Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.
Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.
Email [email protected] to send feedback, show suggestions, or questions to be answered on a later episode.
Follow Going anti-Viral on:
Apple Podcasts
YouTube
X
Facebook
Instagram
...
By Going Anti-Viral5
1616 ratings
In episode 81 of Going anti-Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. Dr Deeks and Dr Saag discuss why a cure for HIV is needed given the effectiveness antiretroviral therapy. Dr Deeks then outlines areas of research demonstrating promise for single-shot functional cures: vector immunotherapy, the use of Chimeric Antigen Receptor (CAR) T cells, and stem cell approaches. Finally, Dr Deeks provides insights into future prospects in HIV cure research including his perspective on the funding and drug development landscape.
0:00 – Introduction
1:21 – The need for a cure beyond antiretroviral therapy
5:37 – Overview of 1-shot cure research
12:40 – The promise of vector immunotherapy
18:52 – Overview of the use of CAR-T cells
25:01 – The role of C-C chemokine receptor type 5 (CCR5) and stem cell approaches
26:36 – Prospects for the future of HIV cure research
__________________________________________________
Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.
Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.
Email [email protected] to send feedback, show suggestions, or questions to be answered on a later episode.
Follow Going anti-Viral on:
Apple Podcasts
YouTube
X
Facebook
Instagram
...

90,994 Listeners

32,100 Listeners

4,038 Listeners

2,055 Listeners

506 Listeners

87,529 Listeners

3,360 Listeners

111,948 Listeners

56,508 Listeners

1,152 Listeners

8,473 Listeners

5,866 Listeners

19 Listeners

15,950 Listeners

10 Listeners